The EPS projection of Arrowhead Research Corporation (NASDAQ:ARWR) for quarter ended 2016-09-30 is $-0.37. A week before, the EPS forecast was $-0.37 against target of $-0.37, a month earlier. This estimate stood at $-0.37 60 days earlier versus forecast of $-0.37 90 days earlier, confirming a deviation of 0%.
Arrowhead Research Corporation (NASDAQ:ARWR) reported that 18 days ago, the positive EPS revisions were 3 and negative revisions at 0.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 3, 3, 1 and 3, respectively.
The downgrade of EPS estimates for Arrowhead Research Corporation (NASDAQ:ARWR) in the preceding 120, 60, 30 and 90 days were 0, 0, 0 and 0, in that order.
As per the latest update, for the quarter closed 2, the EPS estimate of Arrowhead Research Corporation (NASDAQ:ARWR) was $-0.37. This projection was computed after accounting 3 calls. As reported on 2016-05-10 the EPS was $-0.35. The change was $0.02, demonstrating a percentage deviation of 5.41%. The projections confirmed a standard deviation of 0.02.
Quarterly Sales Estimates
For the fiscal 2016, the yearly sales target for Arrowhead Research Corporation (NASDAQ:ARWR) stands at $0.04 and the median estimate at $0.04. Almost 2 analysts announced their estimates.
The highest estimate is $0.04 while the lowest target is $0.04 showing standard deviation of 0%.
As many as 2 analysts released sales estimates reised in upside while 2 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 2 revised sales number projection on upside while 2 lowered the sales target, demonstrating a deviation of -81.818%.
A quarter ago, 2 hiked sales estimations and 2 reduced sales forecast. Arrowhead Research Corporation (NASDAQ:ARWR) stated that the change in forecast was -84.496%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...